Methane;6-(5-methoxy-3-pyridinyl)-N-(6-methylpyridazin-3-yl)-1,3-benzothiazol-2-amine;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-phenyl-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-pyridin-4-yl-1,3-benzothiazol-2-amine
C115H104N26O2S6 — CID 160581546
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methane;6-(5-methoxy-3-pyridinyl)-N-(6-methylpyridazin-3-yl)-1,3-benzothiazol-2-amine;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-phenyl-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-pyridin-4-yl-1,3-benzothiazol-2-amine
Methane;6-(5-methoxy-3-pyridinyl)-N-(6-methylpyridazin-3-yl)-1,3-benzothiazol-2-amine;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-phenyl-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-pyridin-4-yl-1,3-benzothiazol-2-amine (PubChem CID 160581546) has the molecular formula C115H104N26O2S6 and a molecular weight of 2074.68 g/mol. Its IUPAC name is methane;6-(5-methoxy-3-pyridinyl)-N-(6-methylpyridazin-3-yl)-1,3-benzothiazol-2-amine;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-phenyl-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-pyridin-4-yl-1,3-benzothiazol-2-amine.
Molecular Properties
| Compound Name | Methane;6-(5-methoxy-3-pyridinyl)-N-(6-methylpyridazin-3-yl)-1,3-benzothiazol-2-amine;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-phenyl-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-pyridin-4-yl-1,3-benzothiazol-2-amine |
|---|---|
| PubChem CID | 160581546 |
| Molecular Formula | C115H104N26O2S6 |
| Molecular Weight | 2074.68 g/mol |
| Exact Mass | 2072.72 |
| IUPAC Name | methane;6-(5-methoxy-3-pyridinyl)-N-(6-methylpyridazin-3-yl)-1,3-benzothiazol-2-amine;N-(1-methylpyrazol-4-yl)-6-(5-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-methyl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-(6-morpholin-4-yl-3-pyridinyl)-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-phenyl-1,3-benzothiazol-2-amine;6-(5-methyl-3-pyridinyl)-N-pyridin-4-yl-1,3-benzothiazol-2-amine |
| SMILES | C.C.COc1cncc(-c2ccc3nc(Nc4ccc(C)nn4)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4ccc(C)nc4)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4ccc(N5CCOCC5)nc4)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4ccccc4)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4ccncc4)sc3c2)c1.Cc1cncc(-c2ccc3nc(Nc4cnn(C)c4)sc3c2)c1 |
| InChI | InChI=1S/C22H21N5OS.C19H16N4S.C19H15N3S.C18H15N5OS.C18H14N4S.C17H15N5S.2CH4/c1-15-10-17(13-23-12-15)16-2-4-19-20(11-16)29-22(26-19)25-18-3-5-21(24-14-18)27-6-8-28-9-7-27;1-12-7-15(10-20-9-12)14-4-6-17-18(8-14)24-19(23-17)22-16-5-3-13(2)21-11-16;1-13-9-15(12-20-11-13)14-7-8-17-18(10-14)23-19(22-17)21-16-5-3-2-4-6-16;1-11-3-6-17(23-22-11)21-18-20-15-5-4-12(8-16(15)25-18)13-7-14(24-2)10-19-9-13;1-12-8-14(11-20-10-12)13-2-3-16-17(9-13)23-18(22-16)21-15-4-6-19-7-5-15;1-11-5-13(8-18-7-11)12-3-4-15-16(6-12)23-17(21-15)20-14-9-19-22(2)10-14;;/h2-5,10-14H,6-9H2,1H3,(H,25,26);3-11H,1-2H3,(H,22,23);2-12H,1H3,(H,21,22);3-10H,1-2H3,(H,20,21,23);2-11H,1H3,(H,19,21,22);3-10H,1-2H3,(H,20,21);2*1H4 |
| InChIKey | RBVUNGQLNPPUBF-UHFFFAOYSA-N |
| XLogP | 29.60 |
| TPSA | 330.83 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 149 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2074.68 |
| LogP ≤ 5 | 29.60 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 34 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160581546 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.